InvestorsHub Logo
Followers 1
Posts 158
Boards Moderated 0
Alias Born 05/06/2019

Re: None

Friday, 08/28/2020 11:16:35 AM

Friday, August 28, 2020 11:16:35 AM

Post# of 3534
FYI - PAVmed Inc. (PAVM) CEO Lishan Aklog on Q2 2020 Results and Business Aug. 18, 2020

https://seekingalpha.com/article/4369601-pavmed-inc-pavm-ceo-lishan-aklog-on-q2-2020-results-and-business-update-earnings-call?part=single


The research and development plan for our non-invasive laser based blood glucose modern technology, licensed by our subsidiary Solys Diagnostics has made excellent progress during this period. We successfully completed preliminary human testing, demonstrating testing accuracy within established FDA and ISO standards to normal human volunteers with moderately elevated blood glucose after high sugar [meal]. We hope to advance Solys development to achieve FDA and ISO accuracy standards for the full range of blood glucose required by the standards in the coming months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KNW News